Maternal Vaccine Acceptance and Attitudes Before and After the COVID-19 Pandemic: A Narrative Literature Review.

Publication date: Jun 17, 2026

This study aims to assess the acceptance of vaccinations among pregnant women, particularly against influenza, pertussis, COVID-19, and RSV, and to identify factors influencing their willingness to get vaccinated. It also seeks to evaluate the impact of the COVID-19 pandemic on maternal attitudes and behaviors regarding vaccination. The analysis involved a review of existing literature and studies to evaluate the level of vaccine acceptance among pregnant women before and after the COVID-19 pandemic. Factors contributing to vaccine hesitancy, including misinformation, lack of knowledge, and the influence of healthcare professionals, were examined. The findings indicated that, despite scientific evidence supporting the safety and efficacy of vaccines during pregnancy, public concerns remain about their impact on the developing fetus. The outbreak of the COVID-19 pandemic has increased awareness of the risk of infectious diseases, but at the same time, its impact on vaccination rates among pregnant women is ambiguous and geographically diverse. Misinformation and decreased access to healthcare during the pandemic negatively affected vaccine uptake. Trustworthy information provided by healthcare professionals emerged as a key factor in promoting vaccine acceptance. To improve vaccination rates among pregnant women, it is essential to provide clear, evidence-based information through healthcare professionals, particularly those directly caring for pregnant women. Educational campaigns should address concerns calmly and without judgment, emphasizing the safety and benefits of vaccinations. Enhanced access to healthcare and vaccinations, along with strategic information dissemination, can significantly improve vaccine acceptance during pregnancy. Lessons learned from past pandemics should be incorporated into the development of healthcare strategies aimed at implementing recommended vaccinations for pregnant women in the future.

Open Access PDF

Concepts Keywords
Basel vaccinations against COVID-19
Influenza vaccinations against influenza
Misinformation vaccinations against pertussis
Vaccinations vaccinations against RSV
Women

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease MESH influenza
disease MESH pertussis
pathway KEGG Pertussis
disease MESH infectious diseases
drug DRUGBANK Coenzyme M
disease MESH Heart Diseases
pathway REACTOME Immune System
disease MESH included
disease MESH chronic conditions
disease MESH pneumonia
disease MESH preterm birth
disease MESH miscarriage
disease MESH fetal death
disease MESH NHS
drug DRUGBANK Etoperidone
drug DRUGBANK Trestolone
disease MESH SMS
disease MESH gan
drug DRUGBANK Indoleacetic acid
disease MESH tetanus
disease MESH Fac
pathway REACTOME Influenza Infection
disease MESH stillbirth
disease MESH death
disease MESH infection
disease MESH respiratory failure
disease MESH preeclampsia
disease MESH pulmonary embolism
disease MESH RSV infection
drug DRUGBANK Ranitidine
disease MESH respiratory infections
disease MESH emergencies
disease MESH vaccine preventable diseases
drug DRUGBANK Hydroxyethyl Starch
disease MESH hes
drug DRUGBANK Clostridium tetani toxoid antigen (formaldehyde inactivated)
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Dis
disease MESH Tam
drug DRUGBANK Alpha-1-proteinase inhibitor
disease MESH Park
drug DRUGBANK Troleandomycin
drug DRUGBANK Tropicamide
disease MESH Diphtheria
disease MESH Plan
disease MESH injury

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *